Tenth Anniversary of Needlestick Safety & Prevention Act: Charting a Future Path

针刺安全十周年

• 批准号: 8005250
• 负责人: Janine Carol Jagger
• 金额: $ 3万
• 依托单位: UNIVERSITY OF VIRGINIA
• 依托单位国家: 美国
• 财政年份: 2010
• 资助国家: 美国
• 起止时间: 2010-08-01 至 2011-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8005250
• 关键词: Tenth; Anniversary; Needlestick; Safety; Prevention

DESCRIPTION (provided by applicant): Tenth Anniversary of the U.S. Needlestick Safety and Prevention Act: Mapping Progress, Charting a Future Path When the Needlestick Safety and Prevention Act (NSPA) was signed into law on November 6, 2000, the United States (U.S.) became the first country in the world to require the use of safety-engineered sharp medical devices designed to protect healthcare workers from sharps injuries and bloodborne disease transmission. Ten years later, it is time to assess the impact of the NSPA, identify remaining gaps in sharps safety technology, and chart a future path towards eliminating needlesticks as an occupational risk in U.S. healthcare facilities-identified as one of seven "healthcare safety challenges" by the Centers for Disease Control and Prevention in 2001. In order to meet that goal, continued vigilance is necessary to ensure that effective safety technology is both available and consistently used in hospitals and outpatient settings nationwide. The International Healthcare Worker Safety Center at the University of Virginia proposes to hold a conference in 2010 to explore these important issues. Stakeholders from a variety of sectors-healthcare, academia, government, and industry-will be invited to actively participate in shaping an agenda for the next decade that is both national and international in scope. The NSPA has had an impact far beyond the U.S.: it has become a model for sharps safety legislation in other countries, and the European Union is poised to pass an equivalent standard that will greatly accelerate transition to safety technology there. Over the last decade and a half, U.S. medical device companies pioneered the development and marketing of safety-engineered medical devices, driving demand for such products in countries worldwide. The conference will provide an opportunity to discuss the future of the global safety device market, and the hurdles that need to be overcome to bring this potentially life-saving technology to health workers in the poorest countries, who are most at risk of occupational infection. Deliverables from the conference will include a scientific paper reviewing the impact of the NSPA and offering recommendations for achieving further reductions in U.S. needlestick injury rates; a white paper with a strategic plan for extending the benefits of sharps injury technology to health workers in economically challenged regions of the world; and a conference website that includes links to speaker presentations and key recommendations. PUBLIC HEALTH RELEVANCE: The conference will explore successes and challenges over the last decade in addressing a serious occupational risk for healthcare workers: needlestick injuries and occupational blood exposures. More specifically, the conference will examine how the U.S. regulatory and legislative process was successfully used to target a significant public health issue, and the impact of the resulting legislation both in the U.S. and in countries worldwide.

描述（申请人提供）：美国NeedLestick安全和预防法案十周年：映射进度，在2000年11月6日将Needlestick安全和预防法案（NSPA）签署为法律时，在2000年11月6日将其签署为法律，美国（美国）成为世界上第一个使用安全工程敏锐的医疗设备疾病的国家，以保护敏锐的医疗疾病，以保护敏捷的疾病，以保护敏锐的医疗服务。十年后，现在是时候评估NSPA的影响，确定夏普安全技术中的剩余空白，并为消除指定的途径绘制一条途径，以消除针刺作为在美国医疗保健设施中被确定为七个“医疗保健安全挑战”之一的美国医疗保健设施中的职业风险全国设置。 弗吉尼亚大学的国际医疗保健工人安全中心建议在2010年举行一次会议，以探讨这些重要问题。来自各个部门医疗保健，学术界，政府和行业的利益相关者将被邀请积极参与在未来十年中塑造国民和国际范围内的议程。 NSPA的影响远远超出美国。在过去的十年半中，美国医疗设备公司率先开发和营销安全设计的医疗设备，推动了全球国家对此类产品的需求。会议将提供一个机会，讨论全球安全设备市场的未来，以及要克服的障碍，将这项潜在的挽救生命的技术带给最贫穷国家的卫生工作者，这些国家最有可能受到职业感染的风险。 会议中的可交付成果将包括一份科学论文，审查NSPA的影响，并提出建议，以进一步降低美国针刺伤害率；一份具有战略计划的白皮书，旨在将夏普伤害技术的好处扩大到世界经济挑战地区的卫生工作者；以及一个会议网站，其中包括链接到演讲者演示文稿和关键建议。 公共卫生相关性：大会将在过去十年中探索成功和挑战，以应对医疗工作者的严重职业风险：针刺的伤害和职业血液暴露。更具体地说，该会议将研究如何成功地使用美国监管和立法程序来针对重大公共卫生问题，以及在美国和全球国家的立法的影响。